Search

everythinglearnresearchcommunity

for

Search:↓

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

Finasteride and methadone don't increase advanced liver disease risk in HCV+ male veterans.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

Finasteride effectively improves hair growth and slows hair loss in men with male pattern baldness.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

Combination therapy for 9+ months maintains symptom improvements after stopping alpha-blockers or finasteride.

Tamsulosin works faster, but both drugs have similar effects after 6 months.

Topical finasteride with EGCG or TA improves drug release and dermal uptake, potentially treating hair loss effectively.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Finasteride and minoxidil work best together for hair loss.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

Saw palmetto supplements may modestly improve hair regrowth with few side effects, but more research is needed.

Taking alfuzosin and finasteride together caused temporary vision loss in a glaucoma patient, but switching to tamsulosin helped.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Finasteride may cause kidney damage.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

The CDC reports 23 measles cases in unvaccinated US kids, new treatments for eosinophilic esophagitis and osteopenia are approved, poor sleep may cause migraines, atopic dermatitis could lead to asthma, migraines might increase Crohn's disease risk, cancer may raise heart disease risk, gout is linked to prostate issues, Cabo Verde is malaria-free, social factors and vitamin D affect dementia risk, smoking increases hair loss risk, certain drugs might lower thyroid disease risk in arthritis, noma is a neglected disease, and meal timing could impact heart health.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

Ezetimibe effectively reduces prostate size in cases of benign prostatic hyperplasia.

There is no link between hair loss and prostate enlargement.

Gene variation affects prostate issues and hair loss.

Family doctors can manage older men with urinary symptoms using exams, tests, and medications.

Finasteride does not prevent bladder cancer.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.